Rick Alleman, PhD
He obtained a PhD in physiology from the Brody School of Medicine at East Carolina University studying the role of cellular redox control and cardioprotective mechanisms in acute coronary syndromes. His background is in cardiovascular physiology where he has published peer-reviewed research articles in the fields of cardiac, vascular, and metabolic disease. Dr. Alleman’s research focus is on mitochondrial function in the treatment/prevention of acute coronary syndromes and heart failure. Dr. Alleman has worked with biotech companies since 2012 where he has managed preclinical and clinical studies, and developed high throughput screening assays for pharmaceutical drug discovery.